BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9132535)

  • 1. [Self-monitoring of blood coagulation by patients. Principles, procedures and long-term outcome].
    Bernardo A
    Med Monatsschr Pharm; 1997 Feb; 20(2):30-5. PubMed ID: 9132535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term oral coagulation. Self monitoring prevents complication].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Optimizing long-term anticoagulation by patient self-management?].
    Bernardo A
    Z Kardiol; 1998; 87 Suppl 4():75-81. PubMed ID: 9857471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experiences with anticoagulant long term treatment of predominantly cardiologic patients].
    Kubicek F; Praschl E
    Wien Klin Wochenschr; 1968 Nov; 80(44):813-9. PubMed ID: 4974107
    [No Abstract]   [Full Text] [Related]  

  • 5. [New system for testing mechanical heart valves. Self-monitoring at home of anti-vitamin K therapy means greater freedom for the patient].
    Svensson PJ; Follrud C; Thulin L; Berntorp E
    Lakartidningen; 1999 May; 96(20):2478-82. PubMed ID: 10380493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Patient self-monitoring in follow-up of long-term anticoagulant therapy].
    Zerback R; Horstkotte D
    Z Kardiol; 1998; 87 Suppl 4():68-74. PubMed ID: 9857470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Self management of peroral anticoagulant therapy in patients with artificial heart valves].
    Hasenkam JM; Kimose HH; Grønnesby H; Andersen NT; Halborg J; Attermann J; Knudsen L; Christensen TD; Pedersen AM; Lyngbak M; Pilegaard HK
    Ugeskr Laeger; 1998 Nov; 160(47):6811-5. PubMed ID: 9835790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I have an artificial heart valve and am on warfarin for life. I would like to be able to test my own clotting at home. I have heard that there are test devices for this, as there are for diabetics. Why don't more warfarin patients know about them?
    Health News; 2006 Apr; 12(4):16. PubMed ID: 16583499
    [No Abstract]   [Full Text] [Related]  

  • 9. [Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study].
    Cosmi B; Palareti G; Moia M; Pengo V; Testa S
    Minerva Cardioangiol; 1999 Dec; 47(12):598-9. PubMed ID: 10670221
    [No Abstract]   [Full Text] [Related]  

  • 10. [Patient-control method for long term anticoagulant therapy].
    Erdman S; Vidne B; Levy MJ
    Harefuah; 1973 Feb; 84(3):153-5. PubMed ID: 4634044
    [No Abstract]   [Full Text] [Related]  

  • 11. [Patient self-monitoring of oral anticoagulation with CoaguChek].
    Caliezi C; Waber M; Pfiffner D; Saner H; Lämmle B; Wuillemin WA
    Schweiz Med Wochenschr; 2000 Jun; 130(24):916-23. PubMed ID: 10909717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulant prophylaxis: from clinical trials to clinical practice].
    Scardi S; Mazzone C
    G Ital Cardiol; 1998 Feb; 28(2):178-86. PubMed ID: 9534059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hysteroscopic therapy of recurrent hemorrhage in long-term anticoagulant therapy].
    Römer T
    Zentralbl Gynakol; 1994; 116(12):695-6. PubMed ID: 7846983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Better AVK treatment with self monitoring. Dosage can be regulated in time].
    Stigendal L; André U; Christenson B
    Lakartidningen; 1999 May; 96(20):2482, 2485-7. PubMed ID: 10380494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial.
    Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U;
    Thromb Haemost; 2008 Dec; 100(6):1089-98. PubMed ID: 19132235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
    Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
    Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-monitoring versus standard monitoring of oral anticoagulation.
    Ferretti G; Giannarelli D; Carlini P; Felici A; Ciccarese M; Mandalà M; Cognetti F
    Thromb Res; 2007; 119(3):389-90. PubMed ID: 17023029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.